New drug combo tested in Tough-to-Treat lung cancer
Disease control
Completed
This study tested a combination of three drugs—nivolumab, ipilimumab, and plinabulin—for patients whose small cell lung cancer had returned after initial chemotherapy. The goal was to find a safe dose and see if the combination could help control the cancer. The trial involved 39…
Phase: PHASE1, PHASE2 • Sponsor: Salma Sabbour • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC